Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?
| Publicado en: | Current Treatment Options in Oncology Vol. 24; no. 9; pp. 1120 - 1138 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Sep2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173106021&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 173106021 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15272729 3KHC jtl: Current Treatment Options in Oncology issn: 15272729 maglogo: N pubinfo: dt: Sep2023 vid: 24 iid: 9 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 173106021 10.1007/s11864-023-01108-w 173106021 ppf: 1120 ppct: 18 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy? aug: au: Dempsey, Naomi Sandoval, Ana Mahtani, Reshma affil: Miami Cancer Institute, 8900 Kendall Drive, Miami, FL, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|